Structures by: Su D.
Total: 23
BGB-3111
C27H29N5O3
Journal of medicinal chemistry (2019) 62, 17 7923-7940
a=8.6537(3)Å b=8.8678(3)Å c=16.7811(8)Å
α=77.756(4)° β=82.545(4)° γ=68.655(3)°
C18H14F3NO4S
C18H14F3NO4S
Organic & Biomolecular Chemistry (2008) 6, 17 3038-3040
a=8.5833(17)Å b=10.109(2)Å c=10.778(2)Å
α=106.89(3)° β=92.62(3)° γ=108.79(3)°
C45H35Br5O10,3(CH2Cl2),2.25(H2O)
C45H35Br5O10,3(CH2Cl2),2.25(H2O)
New Journal of Chemistry (2008) 32, 9 1478
a=37.319(8)Å b=15.438(5)Å c=21.720(6)Å
α=90.0° β=115.70(10)° γ=90.0°
C54H42Br6O12,2(C8H10)
C54H42Br6O12,2(C8H10)
New Journal of Chemistry (2008) 32, 9 1478
a=11.347(2)Å b=12.878(2)Å c=13.849(2)Å
α=112.802(2)° β=98.427(2)° γ=110.792(2)°
C104H136O40P8
C104H136O40P8
New Journal of Chemistry (2008) 32, 9 1478
a=14.055(2)Å b=14.498(2)Å c=15.077(2)Å
α=75.011(3)° β=88.677(3)° γ=74.754(3)°
C78H102O30P6,0.5(C7H8),H2O
C78H102O30P6,0.5(C7H8),H2O
New Journal of Chemistry (2008) 32, 9 1478
a=15.701(2)Å b=15.946(2)Å c=20.010(2)Å
α=72.218(2)° β=85.667(2)° γ=80.292(2)°
C38H36F12FeN6P2
C38H36F12FeN6P2
Dalton Transactions (2008) 28 3694-3700
a=11.757(3)Å b=23.966(6)Å c=14.510(4)Å
α=90.00° β=96.449(4)° γ=90.00°
C30H28F12FeN4P2
C30H28F12FeN4P2
Dalton Transactions (2008) 28 3694-3700
a=20.062(3)Å b=16.475(3)Å c=19.940(3)Å
α=90.00° β=110.504(3)° γ=90.00°
C28H26Br0.50F9FeN6P1.50
C28H26Br0.50F9FeN6P1.50
Dalton Transactions (2008) 28 3694-3700
a=17.100(5)Å b=20.013(5)Å c=18.983(5)Å
α=90.00° β=114.601(4)° γ=90.00°
P(O)(OEt)2-OAc-Calix(5)
C65H85O25P5
New Journal of Chemistry (2008) 32, 9 1478
a=12.9938(4)Å b=16.3618(5)Å c=18.4136(6)Å
α=100.825(3)° β=94.164(3)° γ=112.261(3)°
Catena-(u2-(1,3-bis(4-pyridyl))propane)-bis(u2-chloro)-lead(II)
C13H14Cl2N2Pb
Acta Crystallographica Section E (2009) 65, 10 m1220
a=4.385(2)Å b=15.455(3)Å c=10.935(2)Å
α=90.00° β=97.65(2)° γ=90.00°
<i>catena</i>-Poly[[[aquapyridinezinc(II)]-μ~2~-3,3-(<i>p</i>-\ phenylene)diacrylato] pyridine solvate]
C17H15NO5Zn,C5H5N
Acta Crystallographica Section E (2010) 66, 9 m1163
a=10.2132(15)Å b=17.375(3)Å c=12.8144(19)Å
α=90.00° β=112.360(2)° γ=90.00°
C32H26Fe2
C32H26Fe2
Inorganic Chemistry (2009) 48, 1857-1870
a=11.929(2)Å b=7.642(2)Å c=12.913(3)Å
α=90° β=93.628(9)° γ=90°
C72H102O24P6,H2O
C72H102O24P6,H2O
Crystal growth & design (2010) 10, 7 3211-3217
a=40.464(5)Å b=17.430(2)Å c=27.483(4)Å
α=90.0° β=123.113(1)° γ=90.0°
C48H54O24P6,4(HNO3),6(H2O)
C48H54O24P6,4(HNO3),6(H2O)
Crystal growth & design (2010) 10, 7 3211-3217
a=12.182(2)Å b=12.332(2)Å c=13.108(2)Å
α=113.447(3)° β=94.212(3)° γ=108.695(3)°
C48H48O24P66,3Ca2,28(H2O)
C48H48O24P66,3Ca2,28(H2O)
Crystal growth & design (2010) 10, 7 3211-3217
a=14.0340(4)Å b=16.2130(5)Å c=19.4062(6)Å
α=110.878(3)° β=95.287(2)° γ=99.200(2)°
C48H46O24P6,Ca4,26.5(H2O)
C48H46O24P6,Ca4,26.5(H2O)
Crystal growth & design (2010) 10, 7 3211-3217
a=11.4113(7)Å b=12.9903(9)Å c=15.4684(11)Å
α=112.047(7)° β=95.814(5)° γ=108.467(6)°
C48H68O16P4,2(H2O)
C48H68O16P4,2(H2O)
Crystal Growth & Design (2009) 9, 8 3575
a=13.0809(7)Å b=25.891(2)Å c=15.9698(8)Å
α=90.00° β=102.257(5)° γ=90.00°
C32H35O16P4,Cs,H2O
C32H35O16P4,Cs,H2O
Crystal Growth & Design (2009) 9, 8 3575
a=10.335(2)Å b=20.680(4)Å c=34.728(6)Å
α=90.0° β=90.0° γ=90.0°
C116H204O16P4,H2O
C116H204O16P4,H2O
Crystal Growth & Design (2009) 9, 8 3575
a=12.105(4)Å b=12.533(3)Å c=39.051(5)Å
α=97.47(2)° β=90.39(2)° γ=94.84(2)°
C52H76O16P4,C7H8,H2O
C52H76O16P4,C7H8,H2O
Crystal Growth & Design (2009) 9, 8 3575
a=12.315(3)Å b=26.087(5)Å c=20.789(4)Å
α=90.0° β=97.05(3)° γ=90.0°
C60H92O16P4,H2O
C60H92O16P4,H2O
Crystal Growth & Design (2009) 9, 8 3575
a=13.247(4)Å b=31.900(10)Å c=15.996(5)Å
α=90.0° β=106.740(5)° γ=90.0°
C19H20EuN8O7,NO3
C19H20EuN8O7,NO3
Inorganic chemistry (2015) 54, 22 10648-10655
a=12.4149(3)Å b=13.0847(2)Å c=16.3421(4)Å
α=90° β=109.920(3)° γ=90°